Viromed Medical AGFRA:VME +0.74%22 PS Ratio is 28.45 as of Jul. 03, 2026, which is 47% below its 10-year median of 53.57. GuruFocus rates FRA:VME with a GF Score™ of 22/100. The stock has 5 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Viromed Medical AG ranks worse than 93.17% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Viromed Medical AG's share price is €6.80.
Viromed Medical AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €0.24. Hence, Viromed Medical AG's PS Ratio for today is 28.45.
The historical rank and industry rank for Viromed Medical AG's PS Ratio or its related term are showing as below:
FRA:VME'
s PS Ratio Range Over the Past 10 Years
Min: 15.82 Med: 53.57 Max: 100.89
Current: 28.45
During the past 5 years, Viromed Medical AG's highest PS Ratio was 100.89. The lowest was 15.82. And the median was 53.57.
FRA:VME's PS Ratio is ranked worse than 93.17% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 2.94
vs FRA:VME: 28.45
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Viromed Medical AG PS Ratio Related Terms
Viromed Medical AG PS Ratio Historical Data
* Premium members only.
The historical data trend for Viromed Medical AG's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Viromed Medical AG's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Viromed Medical AG PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Viromed Medical AG's PS Ratio distribution charts can be found below:
* The bar in red indicates where Viromed Medical AG's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Viromed Medical AG's Share Price of today is €6.80.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Viromed Medical AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €0.24.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Viromed Medical AG (FRA:VME) has a PS Ratio of 28.45 as of Jul. 03, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Viromed Medical AG and its competitors. This is 47% below median its historical median of 53.57. Over the past decade, Viromed Medical AG's PS Ratio has ranged from 15.82 to 100.89. According to the industry distribution chart, Viromed Medical AG ranks #750 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 93.2%.
Is Viromed Medical AG's PS Ratio too high?
Viromed Medical AG's current PS Ratio of 28.45 is 47% below median its 10-year median of 53.57. Over the past 10 years, this metric has ranged from a low of 15.82 to a high of 100.89. The Medical Devices & Instruments industry median PS Ratio is 2.94. Viromed Medical AG's value of 28.45 is 867.7% above this industry median. Based on the distribution chart, Viromed Medical AG ranks #750 out of 805 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Viromed Medical AG has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Viromed Medical AG's PS Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Viromed Medical AG ranks #750 out of 805 companies for PS Ratio. This places Viromed Medical AG in the lower half of its industry. The industry median PS Ratio is 2.94. Viromed Medical AG's value of 28.45 is 867.7% above this benchmark. Historically, Viromed Medical AG's own PS Ratio has ranged from 15.82 to 100.89 over the past decade. While the company's 10-year median is 53.57 vs. the industry median of 2.94, Viromed Medical AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.94, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Viromed Medical AG's current PS Ratio of 28.45 is 867.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Viromed Medical AG and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Viromed Medical AG's current PS Ratio is 28.45, which is 47% below median its own 10-year median of 53.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viromed Medical AG stock overvalued right now?
Viromed Medical AG (FRA:VME) has a current PS Ratio of 28.45. The current PS Ratio is 28.45, which is 47% below median its 10-year median of 53.57 and 867.7% above the Medical Devices & Instruments industry median of 2.94. Viromed Medical AG's overall GF Score™ is 22/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Viromed Medical AG (FRA:VME), the current PS Ratio is 28.45 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Viromed Medical AG is a medical technology company. It focuses on using cold plasma technology to develop medical solutions that protect people from viruses, bacteria, and multi-resistant germs. Viromed's product offerings include ViroCAP, a medical device based on cold plasma technology for treating wounds; ViroCAP derma-podo, a medical device that uses cold atmospheric plasma therapy for skin and foot care; and a Raumluftentkeimer. The company covers the entire value chain from research and development to production, logistics, marketing, and sales of its products.
22GF Score
Get the complete analysis for FRA:VME
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:VME has been successfully added to your 
